Serotonergic-dopaminergic interactions: implications for hyperkinetic disorders.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism*; D009043:Motor Activity / Q000187:drug effects*; D009570:Nitriles / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism*; D011814:Quipazine / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism*
D009570:Nitriles; D012701:Serotonin; C008110:3,3'-iminodipropionitrile; D011814:Quipazine; D006897:Hydroxyindoleacetic Acid; D006220:Haloperidol; D004298:Dopamine; D009638:Norepinephrine